These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10768157

  • 1. [Clinical analysis of the effectiveness and safety of vigabatrin].
    Jedrzejczak J, Owczarek K.
    Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157
    [Abstract] [Full Text] [Related]

  • 2. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.
    Bruni J, Guberman A, Vachon L, Desforges C.
    Seizure; 2000 Apr; 9(3):224-32. PubMed ID: 10777431
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 4. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study].
    Kozik A, Ujma-Czapska B, Grotowska M.
    Neurol Neurochir Pol; 2000 Aug; 34 Suppl 1():187-93. PubMed ID: 10768158
    [Abstract] [Full Text] [Related]

  • 5. Vigabatrin in pediatric patients with refractory epilepsy.
    Turanli G, Celebi A, Yalnizoğlu D, Topçu M, Topaloğlu H, Banu A, Aysun S.
    Turk J Pediatr; 2006 Aug; 48(1):25-30. PubMed ID: 16562782
    [Abstract] [Full Text] [Related]

  • 6. [Lamotrigine versus vigabatrin as an add-on therapy in refractory epilepsy: prospective study].
    Maciejek Z, Niezgodzińska-Maciejek A.
    Neurol Neurochir Pol; 2000 Aug; 34 Suppl 1():165-75. PubMed ID: 10768156
    [Abstract] [Full Text] [Related]

  • 7. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL, Arteaga R, Farr IN, Valdizan E, Beaumont D, Armijo JA.
    J Child Neurol; 1991 Aug; Suppl 2():S45-51. PubMed ID: 1940124
    [Abstract] [Full Text] [Related]

  • 8. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN, Penney S, Buckley DJ.
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [Abstract] [Full Text] [Related]

  • 9. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE, Major P, Halpern E, Thiele EA.
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [Abstract] [Full Text] [Related]

  • 10. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B, Stelmasiak Z.
    Neurol Neurochir Pol; 2008 Jul; 42(4):303-11. PubMed ID: 18975234
    [Abstract] [Full Text] [Related]

  • 11. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
    Friedman D, Bogner M, Parker-Menzer K, Devinsky O.
    Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
    [Abstract] [Full Text] [Related]

  • 12. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA, Dumas C, Ghirardi L.
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [Abstract] [Full Text] [Related]

  • 13. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H, Krämer G.
    Schweiz Med Wochenschr; 1995 Jan 28; 125(4):125-32. PubMed ID: 7878401
    [Abstract] [Full Text] [Related]

  • 14. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
    Kluger G, Berz K, Holthausen H.
    Eur J Paediatr Neurol; 2001 Jan 28; 5(1):37-40. PubMed ID: 11277363
    [Abstract] [Full Text] [Related]

  • 15. [Long-term follow-up of childhood epilepsy treated with vigabatrin outside of clinical trials].
    Garaizar C, Martínez-González MJ, Fernández-Cuesta MA, Prats JM.
    Rev Neurol; 2001 Jan 28; 29(3):201-7. PubMed ID: 10797902
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children.
    Sobaniec W, Kułak W, Strzelecka J, Smigielska-Kuzia J, Boćkowski L.
    Pharmacol Rep; 2005 Jan 28; 57(5):646-53. PubMed ID: 16227648
    [Abstract] [Full Text] [Related]

  • 17. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG, Najam Y, Keegan MB, Whooley M, Madden D, McMenamin JB.
    Seizure; 2005 Mar 28; 14(2):112-6. PubMed ID: 15694564
    [Abstract] [Full Text] [Related]

  • 18. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group.
    Guberman A, Bruni J.
    Seizure; 2000 Mar 28; 9(2):112-8. PubMed ID: 10845734
    [Abstract] [Full Text] [Related]

  • 19. Vigabatrin in low doses selectively suppresses the clonic component of audiogenically kindled seizures in rats.
    Vinogradova LV, Kuznetsova GD, Shatskova AB, van Rijn CM.
    Epilepsia; 2005 Jun 28; 46(6):800-10. PubMed ID: 15946321
    [Abstract] [Full Text] [Related]

  • 20. Vigabatrin therapy in infantile spasms.
    Kankirawatana P, Raksadawan N, Balangkura K.
    J Med Assoc Thai; 2002 Aug 28; 85 Suppl 2():S778-83. PubMed ID: 12403260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.